Patients with severe forms, as was the case with our patient, should receive amphotericin B. Treatment duration correlates with the severity of the disease and the drug used, and it is recommended that it be maintained for six months to one year.
Pacientes con formas graves, como nuestro caso, deben recibir anfotericina B. La duración del tratamiento se correlaciona con la gravedad y la droga utilizada, recomendándose mantenerlo entre seis meses y un año.